Analysis of AMB-FUBINACA Biotransformation Pathways in Human Liver Microsome and Zebrafish Systems by Liquid Chromatography-High Resolution Mass Spectrometry

Overview

Journal Front Chem

Specialty Chemistry

Date 2019 May 2

PMID 31041306

Citations 5

Authors

Duo-Qi Xu

Wen-Fang Zhang

Jing Li

Ji-Fen Wang

Shi-Yang Qin

Jiang-Hai Lu

Affiliations

Soon will be listed here.

Abstract

In this study, the metabolic profiles of a new illicit drug AMB-FUBINACA were investigated using both human liver microsome and zebrafish models. Liquid chromatography Q Extractive HF Hybrid Quadrupole-Orbitrap mass spectrometry (LC-QE-HF-MS) was employed to analyze the metabolic sites and pathways. AMB-FUBINACA was added to the liver microsome incubation model to simulate the metabolic processes in human body. The results showed that a total of 17 metabolites were generated in the human liver microsome model; the main metabolic pathways of the phase I metabolism included ester hydrolysis, methylation, ester hydrolysis combined with decarboxylation, hydroxylation, ester hydrolysis combined with indazole ring hydroxylation, etc. while glucuronidation served as the main metabolic pathway of the phase II metabolism. The zebrafish system produced a similar result with 16 of the same 17 metabolites identified. The phase I metabolites M3.1 (ester hydrolysis), M1.2 (alkyl chain hydrolysis) and the phase II metabolite M3.2 (M3.1 glucuronide) were recommended to be the potential poisoning markers.

Citing Articles

Comparative analysis of the metabolites and biotransformation pathways of fentanyl in the liver and brain of zebrafish.

Liu M, Huang J, Zhao S, Wang B, Zhou H, Liu Y Front Pharmacol. 2024; 14:1325932.

PMID: 38174219 PMC: 10764029. DOI: 10.3389/fphar.2023.1325932.

Characterisation of AMB-FUBINACA metabolism and CB-mediated activity of its acid metabolite.

Webb H, Finlay D, Chen S, Vernall A, Sparkes E, Banister S Forensic Toxicol. 2023; 41(1):114-125.

PMID: 36652070 PMC: 9849163. DOI: 10.1007/s11419-022-00649-3.

Metabolites of Synthetic Cannabinoid 5F-MDMB-PINACA Retain Affinity, Act as High Efficacy Agonists and Exhibit Atypical Pharmacodynamic Properties at CB1 Receptors.

Cabanlong C, Russell L, Fantegrossi W, Prather P Toxicol Sci. 2022; 187(1):175-185.

PMID: 35201352 PMC: 9216042. DOI: 10.1093/toxsci/kfac024.

Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications.

Lobato-Freitas C, Machado Brito-da-Costa A, Dinis-Oliveira R, Carmo H, Carvalho F, Silva J Pharmaceuticals (Basel). 2021; 14(3).

PMID: 33669071 PMC: 7996508. DOI: 10.3390/ph14030186.

Do Toxic Synthetic Cannabinoid Receptor Agonists Have Signature in Vitro Activity Profiles? A Case Study of AMB-FUBINACA.

Finlay D, Manning J, Soes Ibsen M, Macdonald C, Patel M, Javitch J ACS Chem Neurosci. 2019; 10(10):4350-4360.

PMID: 31513380 PMC: 7365684. DOI: 10.1021/acschemneuro.9b00429.

References

Bruni G, Rennekamp A, Velenich A, McCarroll M, Gendelev L, Fertsch E . Zebrafish behavioral profiling identifies multitarget antipsychotic-like compounds. Nat Chem Biol. 2016; 12(7):559-66. PMC: 4912417. DOI: 10.1038/nchembio.2097. View

Valim Brigante T, Abe F, Zuardi A, Hallak J, Crippa J, de Oliveira D . Cannabidiol did not induce teratogenicity or neurotoxicity in exposed zebrafish embryos. Chem Biol Interact. 2018; 291:81-86. DOI: 10.1016/j.cbi.2018.06.008. View

Langer N, Lindigkeit R, Schiebel H, Papke U, Ernst L, Beuerle T . Identification and quantification of synthetic cannabinoids in "spice-like" herbal mixtures: Update of the German situation for the spring of 2016. Forensic Sci Int. 2016; 269:31-41. DOI: 10.1016/j.forsciint.2016.10.023. View

Hsin-Hung Chen M, Dip A, Ahmed M, Tan M, Walterscheid J, Sun H . Detection and Characterization of the Effect of AB-FUBINACA and Its Metabolites in a Rat Model. J Cell Biochem. 2015; 117(4):1033-43. PMC: 5063098. DOI: 10.1002/jcb.25421. View

Bresolin T, de Freitas Rebelo M, Bainy A . Expression of PXR, CYP3A and MDR1 genes in liver of zebrafish. Comp Biochem Physiol C Toxicol Pharmacol. 2005; 140(3-4):403-7. DOI: 10.1016/j.cca.2005.04.003. View

Akamatsu S, Yoshida M . Fragmentation of synthetic cannabinoids with an isopropyl group or a tert-butyl group ionized by electron impact and electrospray. J Mass Spectrom. 2016; 51(1):28-32. DOI: 10.1002/jms.3722. View

Carlier J, Diao X, Sempio C, Huestis M . Identification of New Synthetic Cannabinoid ADB-CHMINACA (MAB-CHMINACA) Metabolites in Human Hepatocytes. AAPS J. 2017; 19(2):568-577. DOI: 10.1208/s12248-016-0037-5. View

Hasegawa K, Wurita A, Minakata K, Gonmori K, Nozawa H, Yamagishi I . Postmortem distribution of MAB-CHMINACA in body fluids and solid tissues of a human cadaver. Forensic Toxicol. 2015; 33(2):380-387. PMC: 4525191. DOI: 10.1007/s11419-015-0272-y. View

Sukardi H, Chng H, Chan E, Gong Z, Lam S . Zebrafish for drug toxicity screening: bridging the in vitro cell-based models and in vivo mammalian models. Expert Opin Drug Metab Toxicol. 2011; 7(5):579-89. DOI: 10.1517/17425255.2011.562197. View

10.

Anghelescu I . "Zombie" Outbreak Caused by Synthetic Cannabinoid. N Engl J Med. 2017; 376(16):1597. DOI: 10.1056/NEJMc1701936. View

11.

Goldsmith P . Zebrafish as a pharmacological tool: the how, why and when. Curr Opin Pharmacol. 2004; 4(5):504-12. DOI: 10.1016/j.coph.2004.04.005. View

12.

Thomas R . The toxicologic and teratologic effects of delta-9-tetrahydrocannabinol in the zebrafish embryo. Toxicol Appl Pharmacol. 1975; 32(1):184-90. DOI: 10.1016/0041-008x(75)90209-4. View

13.

Qian Z, Hua Z, Liu C, Jia W . Four types of cannabimimetic indazole and indole derivatives, ADB-BINACA, AB-FUBICA, ADB-FUBICA, and AB-BICA, identified as new psychoactive substances. Forensic Toxicol. 2016; 34:133-143. PMC: 4705129. DOI: 10.1007/s11419-015-0297-2. View

14.

Achenbach J, Hill J, Hui J, Morash M, Berrue F, Ellis L . Analysis of the Uptake, Metabolism, and Behavioral Effects of Cannabinoids on Zebrafish Larvae. Zebrafish. 2018; 15(4):349-360. DOI: 10.1089/zeb.2017.1541. View

15.

Carlier J, Diao X, Scheidweiler K, Huestis M . Distinguishing Intake of New Synthetic Cannabinoids ADB-PINACA and 5F-ADB-PINACA with Human Hepatocyte Metabolites and High-Resolution Mass Spectrometry. Clin Chem. 2017; 63(5):1008-1021. DOI: 10.1373/clinchem.2016.267575. View